Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis

Shuichi Fujioka, Guido M. Sclabas, Christian Schmidt, Jiangong Niu, Wayne A. Frederick, Qiang G. Dong, James L. Abbruzzese, Douglas B. Evans, Cheryl Baker, Paul J. Chiao

Research output: Contribution to journalArticle

Abstract

We have demonstrated that nuclear factor-κB (NF-κB) is constitutively activated in human pancreatic adenocarcinoma and human pancreatic cancer cell lines but not in normal pancreatic tissues or in immortalized, nontumorigenic pancreatic epithelial cells, suggesting that NF-κB plays a critical role in the development of pancreatic adenocarcinoma. To elucidate the role of constitutive NF-κB activity in human pancreatic cancer cells, we generated pancreatic tumor cell lines that express a phosphorylation defective IκBα (S32, 36A) (IκBαM) that blocks NF-κB activity. In this study, we showed that inhibiting constitutive NF-κB activity by expressing IκBαM suppressed the tumorigenicity of a nonmetastatic human pancreatic cancer cell line, PANC-1, in an orthotopic nude mouse model. Immunohistochemical analysis showed that PANC-1-derived tumors expressed vascular endothelial growth factor (VEGF) and induced angiogenesis. Inhibiting NF-κB signaling by expressing IκBαM significantly reduced expression of Bcl-xL and Bcl-2. The cytokine-induced expression of VEGF and Interleukin-8 in PANC-1 cells is also decreased. Taken together, these results suggest that the inhibition of NF-κB signaling can suppress tumorigenesis of pancreatic cancer cells and that the NF-κB signaling pathway is a potential target for anticancer agents.

Original languageEnglish (US)
Pages (from-to)1365-1370
Number of pages6
JournalOncogene
Volume22
Issue number9
DOIs
StatePublished - Mar 6 2003
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Carcinogenesis
Vascular Endothelial Growth Factor A
Adenocarcinoma
Cell Line
Tumor Cell Line
Interleukin-8
Nude Mice
Human Activities
Antineoplastic Agents
Epithelial Cells
Phosphorylation
Cytokines
Neoplasms

Keywords

  • Angiogenesis
  • IκBα
  • NF-κB
  • Pancreatic cancer
  • Tumorigenesis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Fujioka, S., Sclabas, G. M., Schmidt, C., Niu, J., Frederick, W. A., Dong, Q. G., ... Chiao, P. J. (2003). Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis. Oncogene, 22(9), 1365-1370. https://doi.org/10.1038/sj.onc.1206323

Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis. / Fujioka, Shuichi; Sclabas, Guido M.; Schmidt, Christian; Niu, Jiangong; Frederick, Wayne A.; Dong, Qiang G.; Abbruzzese, James L.; Evans, Douglas B.; Baker, Cheryl; Chiao, Paul J.

In: Oncogene, Vol. 22, No. 9, 06.03.2003, p. 1365-1370.

Research output: Contribution to journalArticle

Fujioka, S, Sclabas, GM, Schmidt, C, Niu, J, Frederick, WA, Dong, QG, Abbruzzese, JL, Evans, DB, Baker, C & Chiao, PJ 2003, 'Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis', Oncogene, vol. 22, no. 9, pp. 1365-1370. https://doi.org/10.1038/sj.onc.1206323
Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG et al. Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis. Oncogene. 2003 Mar 6;22(9):1365-1370. https://doi.org/10.1038/sj.onc.1206323
Fujioka, Shuichi ; Sclabas, Guido M. ; Schmidt, Christian ; Niu, Jiangong ; Frederick, Wayne A. ; Dong, Qiang G. ; Abbruzzese, James L. ; Evans, Douglas B. ; Baker, Cheryl ; Chiao, Paul J. / Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis. In: Oncogene. 2003 ; Vol. 22, No. 9. pp. 1365-1370.
@article{7240711f584548d7894262e7a010b152,
title = "Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis",
abstract = "We have demonstrated that nuclear factor-κB (NF-κB) is constitutively activated in human pancreatic adenocarcinoma and human pancreatic cancer cell lines but not in normal pancreatic tissues or in immortalized, nontumorigenic pancreatic epithelial cells, suggesting that NF-κB plays a critical role in the development of pancreatic adenocarcinoma. To elucidate the role of constitutive NF-κB activity in human pancreatic cancer cells, we generated pancreatic tumor cell lines that express a phosphorylation defective IκBα (S32, 36A) (IκBαM) that blocks NF-κB activity. In this study, we showed that inhibiting constitutive NF-κB activity by expressing IκBαM suppressed the tumorigenicity of a nonmetastatic human pancreatic cancer cell line, PANC-1, in an orthotopic nude mouse model. Immunohistochemical analysis showed that PANC-1-derived tumors expressed vascular endothelial growth factor (VEGF) and induced angiogenesis. Inhibiting NF-κB signaling by expressing IκBαM significantly reduced expression of Bcl-xL and Bcl-2. The cytokine-induced expression of VEGF and Interleukin-8 in PANC-1 cells is also decreased. Taken together, these results suggest that the inhibition of NF-κB signaling can suppress tumorigenesis of pancreatic cancer cells and that the NF-κB signaling pathway is a potential target for anticancer agents.",
keywords = "Angiogenesis, IκBα, NF-κB, Pancreatic cancer, Tumorigenesis",
author = "Shuichi Fujioka and Sclabas, {Guido M.} and Christian Schmidt and Jiangong Niu and Frederick, {Wayne A.} and Dong, {Qiang G.} and Abbruzzese, {James L.} and Evans, {Douglas B.} and Cheryl Baker and Chiao, {Paul J.}",
year = "2003",
month = "3",
day = "6",
doi = "10.1038/sj.onc.1206323",
language = "English (US)",
volume = "22",
pages = "1365--1370",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis

AU - Fujioka, Shuichi

AU - Sclabas, Guido M.

AU - Schmidt, Christian

AU - Niu, Jiangong

AU - Frederick, Wayne A.

AU - Dong, Qiang G.

AU - Abbruzzese, James L.

AU - Evans, Douglas B.

AU - Baker, Cheryl

AU - Chiao, Paul J.

PY - 2003/3/6

Y1 - 2003/3/6

N2 - We have demonstrated that nuclear factor-κB (NF-κB) is constitutively activated in human pancreatic adenocarcinoma and human pancreatic cancer cell lines but not in normal pancreatic tissues or in immortalized, nontumorigenic pancreatic epithelial cells, suggesting that NF-κB plays a critical role in the development of pancreatic adenocarcinoma. To elucidate the role of constitutive NF-κB activity in human pancreatic cancer cells, we generated pancreatic tumor cell lines that express a phosphorylation defective IκBα (S32, 36A) (IκBαM) that blocks NF-κB activity. In this study, we showed that inhibiting constitutive NF-κB activity by expressing IκBαM suppressed the tumorigenicity of a nonmetastatic human pancreatic cancer cell line, PANC-1, in an orthotopic nude mouse model. Immunohistochemical analysis showed that PANC-1-derived tumors expressed vascular endothelial growth factor (VEGF) and induced angiogenesis. Inhibiting NF-κB signaling by expressing IκBαM significantly reduced expression of Bcl-xL and Bcl-2. The cytokine-induced expression of VEGF and Interleukin-8 in PANC-1 cells is also decreased. Taken together, these results suggest that the inhibition of NF-κB signaling can suppress tumorigenesis of pancreatic cancer cells and that the NF-κB signaling pathway is a potential target for anticancer agents.

AB - We have demonstrated that nuclear factor-κB (NF-κB) is constitutively activated in human pancreatic adenocarcinoma and human pancreatic cancer cell lines but not in normal pancreatic tissues or in immortalized, nontumorigenic pancreatic epithelial cells, suggesting that NF-κB plays a critical role in the development of pancreatic adenocarcinoma. To elucidate the role of constitutive NF-κB activity in human pancreatic cancer cells, we generated pancreatic tumor cell lines that express a phosphorylation defective IκBα (S32, 36A) (IκBαM) that blocks NF-κB activity. In this study, we showed that inhibiting constitutive NF-κB activity by expressing IκBαM suppressed the tumorigenicity of a nonmetastatic human pancreatic cancer cell line, PANC-1, in an orthotopic nude mouse model. Immunohistochemical analysis showed that PANC-1-derived tumors expressed vascular endothelial growth factor (VEGF) and induced angiogenesis. Inhibiting NF-κB signaling by expressing IκBαM significantly reduced expression of Bcl-xL and Bcl-2. The cytokine-induced expression of VEGF and Interleukin-8 in PANC-1 cells is also decreased. Taken together, these results suggest that the inhibition of NF-κB signaling can suppress tumorigenesis of pancreatic cancer cells and that the NF-κB signaling pathway is a potential target for anticancer agents.

KW - Angiogenesis

KW - IκBα

KW - NF-κB

KW - Pancreatic cancer

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=0037422205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037422205&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206323

DO - 10.1038/sj.onc.1206323

M3 - Article

C2 - 12618762

AN - SCOPUS:0037422205

VL - 22

SP - 1365

EP - 1370

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 9

ER -